NCT06707207 Predicting Future Errors During Skill Performance
| NCT ID | NCT06707207 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Institute of Neurological Disorders and Stroke (NINDS) |
| Condition | Healthy |
| Study Type | OBSERVATIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-06-17 |
| Primary Completion | 2029-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40 participants in total. It began in 2026-06-17 with a primary completion date of 2029-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Background: Many tasks people do every day require a series of individual movements. Control over these movements is called motor skills. But even highly skilled people can make mistakes. Researchers have found that they can predict when a person will make a mistake 0.1 second before it happens. Now, they want to find out if they can increase that time up to 1 second-long enough to warn the person and prevent the mistake. Objective: To see if motor skill errors can be detected up to 1 second before they occur. Eligibility: Right-handed healthy adults aged 18 to 35. Design: Participants will have 2 to 5 study visits. Each visit will be 1 to 2 hours. They will have a physical and neurological exam. They will have 1 or 2 magnetic resonance imaging (MRI) scans. They will lie on a table that slides into a large cylinder. The MRI uses strong magnets to capture images of the inside of the body, including the brain. They will have another scan, called magnetoencephalography (MEG). Small metal disks attached to wires will be taped to their head. Participants will sit in a padded chair with their head inside of a helmet. The helmet will not cover their eyes or face. Participants will perform a series of typing tasks on a keyboard. They will have short breaks between each round. Their head movements will be tracked, and their eye and finger movements will be videotaped.
Eligibility Criteria
* INCLUSION CRITERIA: In order to be eligible to participate in this study, an individual must meet all of the following criteria: * Stated willingness to comply with all study procedures and availability for the duration of the study * Male or female, aged 18-35 * In good general health as evidenced by medical history and normal neurological examination as determined by the screening clinician * English speaking * Right-handedness as reported by participant * Ability of subject to understand and the willingness to sign a written informed consent document EXCLUSION CRITERIA: An individual who meets any of the following criteria will be excluded from participation in this study: * HCPS-affiliated NIH staff (i.e. - staff from our section) * Current pregnancy * Contraindications for MRI, or MEG * Severe or progressive neurological, psychological or medical condition as determined by the medical history review or physical and neurological exam.
Contact & Investigator
Leonardo G Cohen, M.D.
PRINCIPAL INVESTIGATOR
National Institute of Neurological Disorders and Stroke (NINDS)
Frequently Asked Questions
Who can join the NCT06707207 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 35 Years, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06707207 currently recruiting?
Yes, NCT06707207 is actively recruiting participants. Contact the research team at cathy.blumhorst@nih.gov for enrollment information.
Where is the NCT06707207 trial being conducted?
This trial is being conducted at Bethesda, United States.
Who is sponsoring the NCT06707207 clinical trial?
NCT06707207 is sponsored by National Institute of Neurological Disorders and Stroke (NINDS). The principal investigator is Leonardo G Cohen, M.D. at National Institute of Neurological Disorders and Stroke (NINDS). The trial plans to enroll 40 participants.